Breast cancer remains one of the most commonly diagnosed malignancies and a major cause of cancer-related mortality among women worldwide. Doxorubicin is an anthracycline chemotherapeutic agent widely employed…
Breast cancer remains a leading cause of cancer-related morbidity and mortality among women worldwide. Docetaxel is a potent taxane used in breast cancer chemotherapy; however, its therapeutic application…
shown in the past few years to be important in the study of many cancers. However, while those mutations led to mitochondrial dysfunction and changed energy metabolism, they also increased ... therapy. Using this…
medicine has used herbs for many centuries to treat a variety of ailments including cancer. Discovering the active components in many of these herbs has been a line of research ... from dendrobium nobile stems have…
delivery systems have emerged as a promising strategy to overcome the limitations of conventional cancer therapies, including poor solubility, off-target toxicity, and rapid drug clearance. By integrating multiple…
Background: One of the biggest health problems in the world is depression. Patients with cancer are more likely to experience it because of their inability to cope with the treatment ... depression, associated factors…
Background: Breast cancer is the most common cancer and the leading cause of cancer-related death in women worldwide, with hormone receptor-positive (HR+)/human epidermal growth factor receptor ... negative (HER2-)…
treatment decisions. Automated analysis of biopsy samples can assist the pathologists in grading lung cancer using multi- magnification microscopy images acquired at different magnifications, providing both local and…
using technique immunohistochemistry (IHC); we can categorize Triple negative breast cancer (TNBC) as a diverse disease negative for receptors like human epidermal growth factor receptor 2 (HER2); progesterone receptor…
prevention and mitigation of radiation-induced oral mucositis in patients with head and neck cancer. Methods: In this prospective randomized open-label phase II study; 40 patients were assigned
Cancer remains one of the leading causes of morbidity and mortality worldwide, and its effective treatment continues to be limited by poor drug selectivity, systemic toxicity, multidrug resistance, rapid drug…
Background/Aim: Vulvar cancer is an uncommon gynecologic malignancy that may present with symptoms such as pruritus, pigmentation changes, bleeding, palpable masses, or condylomatous lesions, although some patients…
HER2-targeting antibody-drug conjugate that has demonstrated significant efficacy in HER2-positive gastric cancer in clinical trials. However, real-world evidence across the broader spectrum of digestive malignancies…
Cancer continues to be a leading cause of death globally, necessitating the continuous development of effective therapeutic strategies. This review provides an in-depth exploration of the current landscape ... cancer…
Breast cancer remains one of the leading causes of cancer-related mortality in women worldwide. Eribulin, a microtubule inhibitor, has shown promising therapeutic effects against metastatic breast cancer. However…